ISPECIMEN INC
ISPCNASDAQTrading Snapshot
- Day Range
- $0.84 – $0.88
- 52-Week Range
- $0.79 – $34.00
- Volume (shares)
- 30,448
- Avg Volume (shares)
- —
- Shares Outstanding
- 2.5M
- Next Earnings
- 2026-10-29
Fundamentals Snapshot
- Annual Revenue
- $2M
- Last Q Revenue
- $151,940
- P/E Ratio
- -0.0
- P/S Ratio
- 4.7x
- EPS (TTM)
- $-8.19
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +780.2%
ISPECIMEN INC
ISPC
StockOtter · stockotter.spaceAbout ISPECIMEN INC
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Analyst Ratings
ⓘLatest News & Updates
iSpecimen Inc. (NASDAQ:ISPC) Stock Short Interest Rises 53.3%
iSpecimen Inc. (NASDAQ: ISPC - Get Free Report) was the target of a large growth in short interest in September. As of September 15th, there was short interest totaling 220,722 shares, a growth of 53.3% from the August 3
VivoSim Labs (NASDAQ:VIVS) vs. iSpecimen (NASDAQ:ISPC) Head to Head Comparison
iSpecimen (NASDAQ: ISPC - Get Free Report) and VivoSim Labs (NASDAQ: VIVS - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the str
iSpecimen Supports Hospital Validation of New Chemistry Analyzer
Company coordinates collection of more than 1,700 human specimens to support new laboratory testing capabilities Woburn, Massachusetts--(Newsfile Corp. - September 29, 2026) - iSpecimen, a provider of human biospecimens,
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks
Woburn, Massachusetts--(Newsfile Corp. - August 20, 2026) - iSpecimen, (NASDAQ: ISPC) a provider of human biospecimens, recently completed an international
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
WOBURN, Mass., Aug. 07, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a netw
E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen
Transaction Marks E.F. Hutton's Third Capital Markets Engagement with iSpecimen Since December 2025 Transaction Marks E.F. Hutton's Third Capital Markets Engagement with iSpecimen Since December 2025